Ignite Creation Date:
2025-12-24 @ 7:16 PM
Ignite Modification Date:
2026-04-13 @ 8:42 PM
Study NCT ID:
NCT01652703
Status:
COMPLETED
Last Update Posted:
2018-11-28
First Post:
2012-07-26
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate Tolerability and Efficacy of Evolocumab (AMG 145) in Japanese Subjects
Sponsor:
Amgen
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
20110231
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None